Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.
CONCLUSIONS: OS after SRT was comparable to SM and longer than expected considering patients with adverse risk profiles were common. Fit patients with non-brain metastases treated after an initial period of watchful waiting had the best prognosis.
PMID: 29754859 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Stenman M, Sinclair G, Paavola P, Wersäll P, Harmenberg U, Lindskog M Tags: Radiother Oncol Source Type: research
More News: Brain | Cancer & Oncology | Carcinoma | Kidney Cancer | Neurology | Radiology | Renal Cell Carcinoma | Sweden Health